ARCHIVES

Progress Measures “Adequate,” Committee Says; Suggestions Include New Death Measure

This article is from The Cancer Letter archive.

Vol. 14 No. 33 | August 12, 1988

Download PDF Visit The Full Archive

Related Articles

Phase III Trial of Talimogene Laherparepvec Meets Response Rate Primary Endpoint

March 29, 2013

ASCO Begins Practice Certification Program

June 5, 2009

Bross Claims New Figures Show High Radiation Risk

February 23, 1979

In Brief: NCI Can Proceed With Grant, Contract Awards At Full FY 1978 Level; Rundles Heads ACS

November 18, 1977

In Brief: Healy Nominated to Head NIH; Hammond, D’Angio To Step Down as Group Chairman

January 18, 1991

Litton’s Government Contracts Status Under Review

September 6, 1985